What is Institute of Biomedical Research Corp?
provides biomedical research and analytical services in Montenegro and internationally.
MRES · Verdict
Moderate reward · moderate risk
MRES stands out on volatility and valuation, but watch the profitability signal.
Based on 88% data coverage
MRES · Verdict
Top decile vs peers
Above average
-1279% net margin · 0% ROE
Earnings +55.9% CAGR
Model-based scoring. For information only — not financial advice.
provides biomedical research and analytical services in Montenegro and internationally. Its services include regulatory control of industrial activities and products; scientific surveillance of the living environment; research and development of biomedical products and technologies; regulatory evaluation and certification of biomedical products; fundamental scientific research; and development of new diagnostic methods and experimental medical treatments. The company is listed on the PINK in USA, operating in the Healthcare sector, with a market capitalisation of 6.22M.
The scoring profile indicates limited reward potential at this time, with valuation and momentum offering the most support. Risk indicators are moderate, consistent with typical market exposure.
For informational purposes only. Not financial advice.